NASDAQ:ASMB
$1.68
(
-1.18%
)
Friday, 3rd Feb 2023
Assembly Biosciences Stock Price (Quote)
Range | Low Price | High Price | Comment |
---|---|---|---|
30 days | $1.33 | $1.78 | Friday, 3rd Feb 2023 ASMB stock ended at $1.68. This is 1.18% less than the trading day before Thursday, 2nd Feb 2023. During the day the stock fluctuated 3.61% from a day low at $1.66 to a day high of $1.72. |
90 days | $0.82 | $1.78 | |
52 weeks | $0.82 | $2.42 |
Historical Assembly Biosciences prices
Date | Open | High | Low | Close | Volume |
2023-02-03 | $1.69 | $1.72 | $1.66 | $1.68 | 312 103 |
2023-02-02 | $1.72 | $1.78 | $1.69 | $1.70 | 226 080 |
2023-02-01 | $1.78 | $1.78 | $1.72 | $1.72 | 193 423 |
2023-01-31 | $1.70 | $1.76 | $1.68 | $1.74 | 325 087 |
2023-01-30 | $1.70 | $1.73 | $1.66 | $1.69 | 285 333 |
2023-01-27 | $1.74 | $1.74 | $1.69 | $1.71 | 365 632 |
2023-01-26 | $1.68 | $1.70 | $1.61 | $1.68 | 430 628 |
2023-01-25 | $1.55 | $1.69 | $1.55 | $1.65 | 818 839 |
2023-01-24 | $1.49 | $1.61 | $1.45 | $1.54 | 447 305 |
2023-01-23 | $1.52 | $1.54 | $1.46 | $1.50 | 239 679 |
2023-01-20 | $1.48 | $1.52 | $1.47 | $1.49 | 182 200 |
2023-01-19 | $1.52 | $1.53 | $1.48 | $1.50 | 101 700 |
2023-01-18 | $1.55 | $1.59 | $1.52 | $1.52 | 74 300 |
2023-01-17 | $1.59 | $1.61 | $1.55 | $1.57 | 376 440 |
2023-01-13 | $1.51 | $1.57 | $1.48 | $1.54 | 398 600 |
2023-01-12 | $1.50 | $1.52 | $1.46 | $1.50 | 274 000 |
2023-01-11 | $1.53 | $1.56 | $1.46 | $1.51 | 352 208 |
2023-01-10 | $1.61 | $1.61 | $1.50 | $1.54 | 336 826 |
2023-01-09 | $1.51 | $1.65 | $1.43 | $1.59 | 989 600 |
2023-01-06 | $1.45 | $1.46 | $1.37 | $1.38 | 576 000 |
2023-01-05 | $1.38 | $1.42 | $1.36 | $1.40 | 403 665 |
2023-01-04 | $1.35 | $1.40 | $1.33 | $1.37 | 365 798 |
2023-01-03 | $1.35 | $1.38 | $1.28 | $1.34 | 383 520 |
2022-12-30 | $1.30 | $1.32 | $1.20 | $1.30 | 372 419 |
2022-12-29 | $1.25 | $1.32 | $1.25 | $1.30 | 342 098 |
2022-12-28 | $1.20 | $1.26 | $1.19 | $1.23 | 238 710 |
2022-12-27 | $1.25 | $1.28 | $1.20 | $1.22 | 153 917 |
2022-12-23 | $1.31 | $1.31 | $1.26 | $1.26 | 171 157 |
2022-12-22 | $1.26 | $1.34 | $1.25 | $1.30 | 245 487 |
2022-12-21 | $1.32 | $1.33 | $1.26 | $1.26 | 221 062 |
2022-12-20 | $1.32 | $1.34 | $1.29 | $1.29 | 224 289 |
2022-12-19 | $1.36 | $1.46 | $1.28 | $1.34 | 1 007 154 |
2022-12-16 | $1.15 | $1.17 | $1.13 | $1.17 | 158 359 |
2022-12-15 | $1.18 | $1.18 | $1.15 | $1.16 | 82 750 |
2022-12-14 | $1.20 | $1.22 | $1.17 | $1.17 | 107 637 |
2022-12-13 | $1.15 | $1.25 | $1.15 | $1.20 | 379 523 |
2022-12-12 | $1.11 | $1.25 | $0.82 | $1.13 | 1 428 253 |
2022-12-09 | $1.05 | $1.15 | $1.05 | $1.12 | 679 449 |
2022-12-08 | $1.10 | $1.21 | $1.05 | $1.15 | 326 939 |
2022-12-07 | $1.13 | $1.17 | $1.05 | $1.09 | 392 722 |
2022-12-06 | $1.29 | $1.30 | $1.17 | $1.17 | 390 936 |
2022-12-05 | $1.30 | $1.34 | $1.26 | $1.30 | 380 095 |
2022-12-02 | $1.27 | $1.35 | $1.27 | $1.31 | 165 951 |
2022-12-01 | $1.31 | $1.37 | $1.30 | $1.30 | 681 058 |
2022-11-30 | $1.31 | $1.33 | $1.30 | $1.31 | 112 833 |
2022-11-29 | $1.33 | $1.34 | $1.30 | $1.33 | 136 475 |
2022-11-28 | $1.30 | $1.35 | $1.30 | $1.30 | 131 447 |
2022-11-25 | $1.35 | $1.41 | $1.32 | $1.32 | 60 809 |
2022-11-23 | $1.41 | $1.45 | $1.35 | $1.35 | 157 510 |
2022-11-22 | $1.49 | $1.49 | $1.41 | $1.43 | 163 119 |
About Assembly Biosciences
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical tri... ASMB Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.